Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03797924 · ClinicalTrials.gov registry record · Early Phase 1
Intercostobrachial Nerve Block (ICBN) for Tourniquet Pain: Is it Necessary?
A Early Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 46
- Enrollment target
NCT03797924: Completed Early Phase 1 study, sponsored by University of Florida.
NCT03797924 is a Early Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 46 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03797924, a Early Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
In this study the investigators would like to show that when patients undergo upper limb surgery under supraclavicular brachial plexus block, additional blocking of the Intercostobrachial Nerve Block (ICBN) does not affect the incidence or course of tourniquet pain.
Primary Outcome
Tourniquet pain defined by the presence of dull or aching pain underneath the tourniquet
Interventions
- DRUG Receive ICBN with ropivacaine
- BEHAVIORAL No ICBN block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2019-04-25 |
| Est. Completion | 2021-12-13 |
| Phase | Early Phase 1 |
What the finished NCT03797924 record still lists
NCT03797924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 2 interventions - of which Receive ICBN with ropivacaine is the first listed.
NCT03797924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03797924 about?
NCT03797924 is a clinical study titled "Intercostobrachial Nerve Block (ICBN) for Tourniquet Pain: Is it Necessary?". In this study the investigators would like to show that when patients undergo upper limb surgery under supraclavicular brachial plexus block, additional blocking of the Intercostobrachial Nerve Block (ICBN) does not affect the incidence or course of tourniquet pain.
What is the current status of trial NCT03797924?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 46 participants. The study started on 2019-04-25. Estimated completion is 2021-12-13.
What interventions are being tested in trial NCT03797924?
The interventions under investigation include: Receive ICBN with ropivacaine (DRUG), No ICBN block (BEHAVIORAL).
Who is sponsoring clinical trial NCT03797924?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03797924's enrollment target sits among peer trials
46 566th of 2000 higher than 1,427 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI